Anton Neschadim: News & Coverage - MoneyMakers

Topics

Startup stories Company stories Markets & events People & wealth Family offices

AI & automation

Business automation Industry AI Agents & tools Physical AI

Funding & fundraising Startups & growth Business & growth Acquisitions & ownership

People

All people Investors Angel investors Wealth Founders Boards Executives Leadership changes Get your profile

New Wealth

Explore New Wealth After a business sale Navigating an inheritance Employee equity payouts Large investment gains

Connections Startups Companies Investors Directory Library Get Featured

WatchlistSign in

Home
People
Anton Neschadim
Coverage

AN

MoneyMakers coverage

Anton Neschadim: news & coverage

Page 1 of 1 · 1 report

Founder of ImmunoBiochem.

Published reporting on Anton Neschadim. Entries describe developments as reported on their publication dates.

All reporting

Conceptual illustration for ImmunoBiochem of a blue antibody-like molecule linked by a purple sphere to a receptor on a cell surface, with a larger purple spiky sphere nearby.

Startups & growth Analysis

ImmunoBiochem is developing antibody-directed protein degraders for autoimmune disease

ImmunoBiochem is developing an autoimmune drug candidate that pairs an antibody with a protein-degrading payload. An earlier oncology licence shows one potential route to commercialization.

About Branding Family Offices Articles Stock movers Opportunities List a Business Business Ideas Validate Founders to Watch Get Featured Pricing Business Terms T&C Privacy Refunds Contact

All publications RSS News RSS Guides RSS